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Murine typhus was diagnosed by PCR in 50 (7%) of 
756 adults with febrile illness seeking treatment at Patan 
Hospital in Kathmandu, Nepal. Of patients with murine ty-
phus, 64% were women, 86% were residents of Kathmandu, 
and 90% were unwell during the winter. No characteristics 
clearly distinguished typhus patients from those with blood 
culture–positive enteric fever.  
I
n 2001, we found Salmonella enterica serotype Typhi 
and S. enterica serotype Paratyphi A to be the most com-
mon causes of bloodstream infections among adults with 
febrile illness who sought treatment at Patan Hospital in 
Kathmandu, Nepal (1). Another important ﬁ  nding was the 
relatively high percentage of patients (11%) who had im-
munoglobulin (Ig) M antibodies against Rickettsia typhi in 
peripheral blood. Because most testing was performed on 
unpaired acute-phase sera, and a high percentage of sero-
positive results were found in a group of healthy study par-
ticipants, we were uncertain whether these participants had 
acute murine typhus or more distant past infection. 
Recent studies have shown the value of PCR for di-
agnosing scrub typhus (2–4), and a real-time assay for 
R. typhi has recently been validated (5). In our study, we 
tested archived blood samples from our febrile adult cohort 
(1) with this R. typhi PCR to better characterize the inci-
dence of murine typhus and to determine whether clinical 
features could help distinguish murine typhus from enteric 
(typhoid) fever.
The Study
We studied consecutive adult patients with fever (ax-
illary temperature >38°C; >13 years of age) who sought 
treatment at Patan Hospital from January 15 through 
March 15, 2001 (winter) and July 2 through August 10, 
2001 (summer), as detailed elsewhere (1). The study was 
approved by the Nepal Health Research Council and the 
Institutional Review Board of the Centers for Disease Con-
trol and Prevention.
Blood from each patient was injected into blood cul-
ture bottles and serum samples were tested for R. typhi 
IgM antibodies (INDX Multi-Test Dip-S-Ticks SDLST; 
Integrated Diagnostics, Inc., Baltimore, MD, USA). In 
addition, whole blood samples (stored at −80ºC) were 
tested by real-time PCR for R. typhi at the Naval Medi-
cal Research Center, Silver Spring, MD (NMRC) and 
at Canterbury Health Laboratories, Christchurch, New 
Zealand (CHL). Details of the assay have been described 
elsewhere (5). We extracted DNA from 200 μL of whole 
blood and used primers and probes speciﬁ  c to a portion of 
the outer membrane protein B (ompB) unique to R. typhi 
to amplify and detect the target sequence in a SmartCy-
cler (Cepheid, Sunnyvale, CA, USA) at NMRC and in a 
LightCycler (Roche Diagnostics, Mannheim, Germany) 
thermocycler at CHL. Thermocycling parameters includ-
ed an initial denaturation step (2 min at 9°C) followed by 
45 cycles of denaturation (94°C for 5 s) and annealing/
elongation (60°C for 30 s) steps. Positive samples were 
deﬁ   ned as those that demonstrated ﬂ  uorescence  above 
background levels. Template-free controls assayed at the 
same time and under the same conditions as the experi-
mental and positive control samples consistently showed 
negative results.
In our study, a diagnosis of murine typhus required a 
positive R. typhi PCR result; a diagnosis of enteric fever re-
quired a positive blood culture for S. Typhi or S. Paratyphi. 
Data from patients with murine typhus were compared with 
those from patients with enteric fever by using the χ2 test 
or Fisher exact test for dichotomous and ordinal variables, 
and 2-sided Wilcoxon rank sum test and the Student t test 
for continuous variables. We used multivariable logistic 
regression analysis to further evaluate variables associated 
with murine typhus. Murine typhus was the outcome vari-
able in the ﬁ  nal model; other variables were those associ-
ated with the outcome with p<0.1 on bivariable analysis. 
Data were analyzed by using STATA version 8.2 (Stata-
Corp, College Station, TX, USA). 
We enrolled 876 patients, 370 in winter and 506 in 
summer. In 323 (37%) patients, a putative diagnosis was 
established; 117 (13%) patients had positive blood cultures 
for S. Typhi or S. Paratyphi A. 
Whole blood samples were available for testing from 
756 (86%) patients. Of these patients, 85 (11%) had R. 
typhi IgM antibodies detected in acute-phase serum sam-
ples and 50 (7%) had positive R. typhi PCR results; 11 
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(13%) of the R. typhi–seropositive patients were also PCR 
positive. Sequencing of amplicons from 5 PCR-positive 
patients showed 100% similarity with the reference strain 
of R. typhi (GenBank accession no. AE017197). None of 
the patients with positive PCR results for R. typhi had a 
positive blood culture.
The features of the 50 patients with murine typhus and 
the 94 patients with enteric fever are presented in the Table; 
all had negative R. typhi PCR results. Sixteen of the murine 
typhus patients had chest radiographs; 6 (38%) of these pa-
tients were reported as having lung inﬁ  ltrates. Of the 50 
patients with murine typhus, 45 were managed as outpa-
tients and 5 were ill enough to be admitted to a hospital. No 
deaths occurred.
After logistic regression analysis, only 3 variables 
were signiﬁ  cantly associated with murine typhus compared 
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Table. Demographic, clinical, and laboratory features of patients with murine typhus and enteric fever, Nepal*  
Variable Murine typhus, n = 50 Enteric fever, n = 94 p value
Demographics
Age, y, median (range) 28 (15–85)  22 (14–72)  0.0001
Male gender 18 (36)  61 (65)  0.001
Occupation 0.001
   Housewife  17 (41)  10 (12) 
 Student 7 (17)  36 (42) 
 Business  person 2 (5)  7 (8) 
 Government  employee 2 (5)  8 (9) 
 Other 13 (32)  24 (28) 
Residence <0.001
  Kathmandu  31 (86)  27 (32) 
 Patan 0 28 (33)
 Kathmandu  Valley 4 (11)  10 (12) 
 Other 1 (3)  20 (24) 
Winter season 45 (90)  27 (29)  <0.001
Admission diagnosis <0.001
  Enteric fever 21 (42)  66 (70) 
  Lower respiratory tract infection 13 (26)  3 (3) 
  Urinary tract infection 6 (12)  3 (3) 
  Upper respiratory tract infection 3 (6)  1 (1) 
 Other 7 (14)  21 (22) 
Symptoms
  Cough 33 (66)  30 (33)  <0.001
  Shortness of breath 16 (32)  6 (7)  <0.001
 Nausea 14 (28)  34 (37)  0.26
 Diarrhea 5 (10)  16 (18)  0.24
 Abdominal  pain 16 (33)  25 (28)  0.58
 Headache 41 (82)  78 (86)  0.56
 Joint  pain 12 (24)  11 (12)  0.07
Duration of symptoms, d, median (range) 5 (1–10)  5 (1–30)  0.23
Examination findings
  Temperature, °C, mean (SD) 38.9 (0.7)  38.8 (0.6)  0.54
  Respiratory rate, breaths/min, mean (SD) 26 (9)  21 (5)  0.0002
  Heart rate, beats/min, mean (SD) 112 (17)  105 (15)  0.02
  Systolic blood pressure, mm Hg, mean (SD) 109 (17)  107 (11)  0.52
  Diastolic blood pressure, mm Hg, mean (SD) 70 (10)  70 (8)  0.88
 Crackles 13 (26)  8 (9)  0.006
Hepatomegaly 2 (4)  9 (10)  0.22
Splenomegaly 2 (4)  12 (13)  0.09
Rash 01 ( 1 ) 0 . 4 6
Laboratory findings
  Hematocrit, %, mean (SD) 39 (6)  39 (5)  0.70
  Leukocyte count, cells × 10
9/L, median (IQR) 8.9 (6.2–11.1)  5.8 (4.8–7.6)  <0.001
  Neutrophils,  %,  median  (IQR) 83 (74–87)  68 (60–73)  <0.001
    Lymphocytes, %, median (IQR) 13 (9–22)  27 (20–35)  <0.001
    Monocytes, %, median (IQR) 2.5 (1–5)  2 (0–4)  0.57
    Eosinophils, %, median (IQR) 0.5 (0–2)  0 (0–2)  0.80
*Data are no. (%) unless otherwise stated. SD, standard deviation; IQR, interquartile range. with enteric fever. These variables were age (for each in-
crease by 1 year) (odds ratio [OR) 1.07, 95% conﬁ  dence in-
terval [CI] 1.00–1.16, p = 0.05); Kathmandu residence (OR 
14.37, 95% CI 1.07–193.39, p = 0.05); and winter season 
(OR 28.93, 95% CI 2.47–338.93, p = 0.007).
Conclusions
We detected R. typhi DNA in blood from 7% of the 
febrile adult study population from urban Nepal. This ﬁ  nd-
ing is likely to be an underestimate of the actual extent of 
rickettsial disease because of the small volume of blood 
tested in each PCR and possible sample deterioration dur-
ing transport and storage (between sample collection and 
testing). Although PCR has yet to be extensively evaluated 
for the diagnosis of murine typhus (5–8), a sizeable body 
of evidence supports the high sensitivity and speciﬁ  city of 
PCR for the diagnosis of rickettsial diseases (2,4,9,10). The 
real-time PCR used in our study has a high analytical sen-
sitivity and speciﬁ  city for R. typhi (5), and sequencing of 
amplicons from our patients further supports the speciﬁ  city 
of the assay. In addition, none of our patients with murine 
typhus had positive blood cultures. 
The results of this and other (11,12) studies indicate 
that murine typhus is an important endemic infection in Ne-
pal. Although our study did not extend throughout the full 
year, murine typhus was more common in winter than in 
summer. This ﬁ  nding contrasts with the summer–autumn 
predominance reported in other regions (13,14). We also 
noted a clear predominance of cases from Kathmandu and 
none from the Patan side of the city, despite the fact that 
the latter is the main catchment area for Patan Hospital. It 
is possible that an outbreak of murine typhus occurred in 
Kathmandu during the winter of 2001, and epidemiologic 
studies are needed to clarify whether there is a focus of mu-
rine typhus activity in Kathmandu. In Nepal, enteric fever 
is one of the most common causes of febrile illness (1,15). 
We identiﬁ  ed no reliable clinical marker to distinguish mu-
rine typhus from enteric fever, and the classic clinical triad 
of rickettsial diseases (headache, fever, and rash) was not 
detected in any of our patients. Murine typhus should be 
considered as an alternative diagnosis in patients with sus-
pected enteric fever in Nepal. This diagnosis is especially 
important given that ﬁ  rst-line antimicrobial drug therapy is 
different for the 2 diseases. 
Our study highlights the importance of rickettsial in-
fections as a cause of febrile illness in Kathmandu. Further 
epidemiologic and ecologic studies are needed to better 
clarify the features of murine typhus in Nepal.  
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